Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis

European Journal of Pharmacology

Volumn 460, Issue 1, 2003, Pages 1-8

  Hatziapostolou, Maria ^a   Katsoris, Panagiotis ^a   Papadimitriou, Evangelia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Angiostatin; Plasmin; 2 Antiplasmin; Aminocaproic acid

Indexed keywords

AMINOCAPROIC ACID; ANGIOSTATIN; ANTIPLASMIN; MATRIGEL; PLASMIN; PLASMIN INHIBITOR; PROTEIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DETERMINATION; UMBILICAL VEIN;

EID: 0037466841     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02868-6     Document Type: Article

References (47)

1. Andreasen P.A., Kjollerm L., Christensen L., Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis. Int. J. Cancer. 72:1997;1-22.
2. Andreasen P.A., Egelund R., Petersen H.H. The plasminogen activation system in tumor growth, invasion and metastasis. Cell. Mol. Life Sci. 57:2000;25-40.
3. Ausprunk D.H., Knighton D.R., Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol. 38:1974;237-248.
4. Benelli R., Morini M., Carrozzino F., Ferrari N., Minghelli S., Santi L., Cassatella M., Noonan D.M., Albini A. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J. 16:2002;267-269.
5. Cao R., Wu H.-L., Veitonmaki N., Linden P., Farnebo J., Shi G.-Y., Cao Y. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5728-5733.
6. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
7. Collen D. On the regulation and control of fibrinolysis. Thromb. Haemost. 43:1980;77-89.
8. Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., Pierce R.A., Shapiro S.D. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161:1998;6845-6852.
9. Devy L., Blacher S., Grignet-Debrus C., Bajou K., Masson V., Gerard R.D., Gils A., Carmeliet G., Carmeliet P., Declerck P.J., Noel A., Foidart J.M. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J. 16:2002;147-154.
10. Dong Z., Kumar R., Yang X., Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 88:1997;801-810.
11. Falcone D.J., Borthll W., McCaffrey T.A., Mathew J., McAdam K. Regulation of macrophage receptor-bound plasmin by autoproteolysis. J. Biol. Chem. 269:1994;32660-32666.
12. Falcone D.J., Khan K.M., Layne T., Fernandes L. Macrophage formation of angiostatin during inflammation. J. Biol. Chem. 273:1998;31480-31485.
13. Gately S., Twardowski P., Stack M.S., Cundiff D.L., Grella D., Castellino F.J., Enghild J., Kwaan H.C., Lee F., Kramer R.A., Volpert O., Bouck N., Soff G.A. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10868-10872.
14. Giannopoulou E., Katsoris P., Hatziapostolou M., Kardamakis D., Kotsaki E., Polytarchou C., Parthymou A., Papaioannou S., Papadimitriou E. X-rays modulate extracellular matrix in vivo. Int. J. Cancer. 94:2001;690-698.
15. Giannopoulou E., Katsoris P., Polytarchou C., Papadimitriou E. Nitration of cytoskeletal proteins in the chicken embryo chorioallantoic membrane. Arch. Biochem. Biophys. 400:2002;188-198.
16. Giannopoulou E., Katsoris P., Kardamakis P., Papadimitriou E. Amifostine inhibits angiogenesis in vivo. J. Pharmacol. Exp. Ther. 304:2003;. (in press).
17. Gonias S.L., Braud L.L., Geary W.A., Vandenberg S.R. Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver. Blood. 74:1989;729-736.
18. 2-macroglobulin. J. Biol. Chem. 266:1991;12329-12336.
19. Hari D., Beckett M.A., Sukhatme V.P., Dhanabal M., Nodzenski E., Lu H., Mauceri H.J., Kufe D.W., Weichselbaum R.R. Angiostatin induces mitotic cell death of proliferating endothelial cells. Mol. Cell. Biol. Res. Commun. 3:2000;277-282.
20. Humphries J.E., Vasudevan J., Gonias S.L. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin. Arterioscler. Thromb. 13:1993;48-55.
21. Ji W.R., Castellino F.J., Chang Y., Deford M.E., Gray H., Villarreal X., Kondri M.E., Marti D.N., Llinas M., Schaller J., Kramer R.A., Trail P.A. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J. 12:1998;1731-1738.
22. Kisker O., Onizuka S., Banyard J., Komiyama T., Becker C.M., Achilles E.G., Barnes C.M., O'Reilly M.S., Folkman J., Pirie-Shepherd S.R. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Cancer Res. 61:2001;7298-7304.
23. Lerch P.G., Rickli E.E., Lergier W., Gillessen D. Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. Eur. J. Biochem. 107:1980;7-13.
24. Lin L.F., Houng A., Reed G.L. Epsilon amino caproic acid streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms. Biochemistry. 39:2000;4740-4745.
25. Miles L.A., Plow E.F. Binding and activation of plasminogen on the platelet surface. J. Biol. Chem. 260:1985;4303-4311.
26. Morikawa W., Yamamoto K., Ishikawa S., Takemoto S., Ono M., Fukushi J., Naito S., Nozaki C., Iwanaga S., Kuwano M. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J. Biol. Chem. 275:2000;38912-38920.
27. O'Reilly M.S., Wiederschain D., Stetler-Stevenson W.G., Folkman J., Moses M.A. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. 274:1999;29568-29571.
28. Papadimitriou E., Heroult M., Courty J., Polykratis A., Stergiou C., Katsoris P. Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides. Biochem. Biophys. Res. Commun. 274:2000;242-248.
29. Papadimitriou E., Polykratis A., Courty J., Koolwijk P., Heroult M., Katsoris P. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides. Biochem. Biophys. Res. Commun. 282:2001;306-313.
30. Patterson B.C., Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272:1997;28823-28825.
31. Pedersen H., Brunner N., Francis D., Osterlind K., Ronne E., Hansen H.H., Dano K., Grondahl-Hansen J. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res. 54:1994;4671-4675.
32. Pedersen H., Grondahl-Hansen J., Francis D., Osterlind K., Hansen H.H., Dano K., Brunner N. Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma. Cancer Res. 54:1994;120-123.
33. Pepper M.S. Extracellular proteolysis and angiogenesis. Thromb. Haemost. 86:2001;346-355.
34. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21:2001;1104-1107.
35. Pepper M.S., Montesano R., Mandriota S., Orci L., Vassali J.D. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein. 49:1996;138-162.
36. Pipili-Synetos E., Papadimitriou E., Maragoudakis M.E. Evidence that platelets promote tube formation by endothelial cells in vitro. Br. J. Pharmacol. 125:1998;1252-1257.
37. Pipili-Synetos E., Kritikou S., Papadimitriou E., Athanassiadou A., Flordellis C., Maragoudakis M.E. Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane. Br. J. Pharmacol. 129:2000;207-213.
38. Ribatti D., Leali D., Vacca A., Giuliani R., Gualandris A., Roncali L., Nolli M.L., Presta M. In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. J. Cell Sci. 112:1999;4213-4221.
39. Sack R.A., Beaton A.R., Sathe S. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Curr. Eye Res. 18:1999;186-193.
40. Scapini P., Nesi L., Morini M., Tanghetti E., Belleri M., Noonan D., Presta M., Albini A., Cassatella M.A. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J. Immunol. 168:2002;5798-5804.
41. Silverstein R.L., Friedlander R.J. Jr., Nicholas R.L., Nachman R.L. Binding of Lys-plasminogen to monocytes/macrophages. J. Clin. Invest. 82:1988;1948-1955.
42. Soff G.A. Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev. 19:2000;97-107.
43. 4.5: a naturally occurring human angiogenesis inhibitor. Proc. Am. Assoc. Cancer Res. 40:1999;4088-4096.
44. Stathakis P., Fitzgerald M., Matthias L.J., Chesterman C.N., Hogg P.J. Generation of angiostatin by reduction and proteolysis of plasmin. J. Biol. Chem. 272:1997;20641-20645.
45. Tarui T., Miles L.A., Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J. Biol. Chem. 276:2001;39562-39568.
46. Tarui T., Majumdar M., Miles L.A., Ruf W., Takada Y. Plasmin-induced migration of endothelial cells: a potential target for the anti-angiogenic action of angiostatin. J. Biol. Chem. 277:2002;22564-33570.
47. 2-antiplasmin. Methods Enzymol. 80:1981;395-408.